Compile Data Set for Download or QSAR
Report error Found 92 Enz. Inhib. hit(s) with Target = 'UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit'
TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50548078(CHEMBL4746798)
Affinity DataIC50: 0.0280nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524090(US11136337, Example 4.1 | 6-{[3-(2-Fluoropyridin-3...)
Affinity DataIC50: 0.0340nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524080(US11136337, Example 2.1 | 6-{[3-(2-Fluorophenyl)-1...)
Affinity DataIC50: 0.0350nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524098(US11136337, Example 4.9)
Affinity DataIC50: 0.0400nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524101(US11136337, Example 4.12)
Affinity DataIC50: 0.0760nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524097(US11136337, Example 4.8)
Affinity DataIC50: 0.0960nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524091(US11136337, Example 4.2)
Affinity DataIC50: 0.110nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524092(US11136337, Example 4.3)
Affinity DataIC50: 0.120nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524099(US11136337, Example 4.10)
Affinity DataIC50: 0.150nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524095(US11136337, Example 4.6)
Affinity DataIC50: 0.170nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524084(US11136337, Example 2.5)
Affinity DataIC50: 0.180nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524100(US11136337, Example 4.11)
Affinity DataIC50: 0.190nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524103(US11136337, Example 4.14)
Affinity DataIC50: 0.200nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524081(US11136337, Example 2.2)
Affinity DataIC50: 0.230nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524082(US11136337, Example 2.3)
Affinity DataIC50: 0.280nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524093(US11136337, Example 4.4)
Affinity DataIC50: 0.290nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524096(US11136337, Example 4.7)
Affinity DataIC50: 0.370nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524102(US11136337, Example 4.13)
Affinity DataIC50: 0.380nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524074(US11136337, Example 1.4)
Affinity DataIC50: 0.510nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524077(US11136337, Example 1.7)
Affinity DataIC50: 0.600nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524107(US11136337, Example 6.1 | 6-[(2H-Indazol-2-yl)meth...)
Affinity DataIC50: 0.690nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524108(US11136337, Example 7.1 | 6-{[3-(3,3-Difluoropyrro...)
Affinity DataIC50: 0.840nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524076(US11136337, Example 1.6)
Affinity DataIC50: 0.960nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524087(US11136337, Example 3.2)
Affinity DataIC50: 1.20nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524078(US11136337, Example 1.8)
Affinity DataIC50: 1.40nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524072(US11136337, Example 1.2)
Affinity DataIC50: 1.60nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524083(US11136337, Example 2.4)
Affinity DataIC50: 1.70nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524071(US11136337, Example 1.1 | Ethyl 1-({7-amino-5-meth...)
Affinity DataIC50: 1.70nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524073(US11136337, Example 1.3)
Affinity DataIC50: 2.20nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524088(US11136337, Example 3.3)
Affinity DataIC50: 2.60nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524111(US11136337, Example 8.1 | Benzyl N-(1-{[1-({7-amin...)
Affinity DataIC50: 3.20nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524086(US11136337, Example 3.1 | 1.1 6-{[4-(3-Methanesulf...)
Affinity DataIC50: 3.30nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524075(US11136337, Example 1.5)
Affinity DataIC50: 3.30nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524109(US11136337, Example 7.2)
Affinity DataIC50: 3.5nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524105(US11136337, Example 4.16)
Affinity DataIC50: 3.60nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524094(US11136337, Example 4.5)
Affinity DataIC50: 3.80nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524079(US11136337, Example 1.9)
Affinity DataIC50: 4.40nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524085(US11136337, Example 2.6)
Affinity DataIC50: 4.40nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524110(US11136337, Example 7.3)
Affinity DataIC50: 5.10nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524089(US11136337, Example 3.4)
Affinity DataIC50: 5.10nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524104(US11136337, Example 4.15)
Affinity DataIC50: 5.60nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524112(US11136337, Example 9.1 | 6-({3-[(4,4-Difluoropipe...)
Affinity DataIC50: 7.40nMAssay Description:Each assay plate contains wells with vehicle controls (1% DMSO) for the measurement of non-inhibited transfer reaction (=100% Ctl) and wells with 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50365463(CHEMBL1232461)
Affinity DataKd:  223nMAssay Description:Binding affinity against OGT (unknown origin) assessed as apparent dissociation constant incubated for 1 hr by colloidal coomassie staining based LC-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM147133(US8957075, Table 1 Compound 28)
Affinity DataKd:  400nMAssay Description:384-well plates (Costar #3654) were filled using a liquid handling robot with 20 uL of a mixture of 50 nM of a fluorescein-linked UDP-GlcNAc analog (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/10/2015
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50365463(CHEMBL1232461)
Affinity DataIC50: 480nMAssay Description:Inhibition of OGT (unknown origin) incubated for 1 hr by colloidal coomassie staining based LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM147117(US8957075, Table 1 Compound 12)
Affinity DataKd:  1.60E+3nMAssay Description:384-well plates (Costar #3654) were filled using a liquid handling robot with 20 uL of a mixture of 50 nM of a fluorescein-linked UDP-GlcNAc analog (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/10/2015
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50118239(uridine 5'-(trihydrogen diphosphate) | UDP | Uridi...)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of human OGTMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2011
Entry Details Article
PubMed
TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM147110(US8957075, Table 1 Compound 4)
Affinity DataKd:  2.00E+3nMAssay Description:384-well plates (Costar #3654) were filled using a liquid handling robot with 20 uL of a mixture of 50 nM of a fluorescein-linked UDP-GlcNAc analog (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/10/2015
Entry Details
US Patent

TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50637321(CHEMBL5559419)
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibition of OGT (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM147116(US8957075, Table 1 Compound 11)
Affinity DataKd:  3.20E+3nMAssay Description:384-well plates (Costar #3654) were filled using a liquid handling robot with 20 uL of a mixture of 50 nM of a fluorescein-linked UDP-GlcNAc analog (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/10/2015
Entry Details
US Patent

Displayed 1 to 50 (of 92 total ) | Next | Last >>
Jump to: